Voting Rights Announcements | 8 October 2012 20:08


STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

08.10.2012 20:08

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


1. Threadneedle Asset Management Holdings SARL

Threadneedle Asset Management Holdings SARL, Luxembourg, Luxembourg, has
notified us pursuant to sec. 21 para. 1 WpHG on 5 October 2012, that on 4
October 2012 the share of voting rights in STRATEC Biomedical AG,
Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and
that the percentage of voting rights on that day amounted to 4.90% (575,347
voting rights).
Threadneedle Asset Management Holdings SARL has notified us that these
voting rights of 4.90% (575,347 voting rights) are attributable to
Threadneedle Asset Management Holdings SARL pursuant to sec. 22 para. 1
sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management Holdings
SARL inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.



2. Ameriprise Financial, Inc.

Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to sec. 21 para. 1 WpHG on 5 October 2012, that on 4 October 2012
the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany,
ISIN: DE0007289001 went below the threshold of 5% and that the percentage
of voting rights on that day amounted to 4.96% (582,627 voting rights).
Ameriprise Financial, Inc. has notified us that these voting rights of
4.96% (582,627 voting rights) are attributable to Ameriprise Financial,
Inc. pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2
WpHG.
The voting rights were attributed to Ameriprise Financial, Inc. inter alia
from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or
more of the voting rights in STRATEC Biomedical AG.



08.10.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------